Matches in SemOpenAlex for { <https://semopenalex.org/work/W2614596316> ?p ?o ?g. }
- W2614596316 endingPage "10823" @default.
- W2614596316 startingPage "10813" @default.
- W2614596316 abstract "In 95% of patients with pancreatic ductal adenocarcinoma, recurrence is observed following chemotherapy. Findings from several studies have indicated that cancer stem cells (CSCs) are resistant to anticancer agents and may be involved in cancer recurrence and metastasis. The CD44 protein is a major CSC marker, and CD44 also plays an indispensable role in the CSC properties in several cancers, including pancreatic cancer; however, no clinical approach exists to inhibit CD44 activity. Here, we have performed knock-in/knockdown experiments, and we demonstrate that the forkhead box O3 (FOXO3)/liver kinase B1 (LKB1)/AMP-activated protein kinase/peroxisome proliferator-activated receptor-γ co-activator-1β (PGC-1β)/pyruvate dehydrogenase-A1 pathway is essential for CD44 expression and CSC properties. We observed that patients exhibiting high pyruvate dehydrogenase-A1 expression have a poor prognosis. Systemic PGC-1β knock-out mice are fertile and viable and do not exhibit an overt phenotype under normal conditions. This suggests that cGMP induction and PGC-1β inhibition represent potential strategies for treating patients with pancreatic ductal adenocarcinoma." @default.
- W2614596316 created "2017-05-26" @default.
- W2614596316 creator A5009883829 @default.
- W2614596316 creator A5010706963 @default.
- W2614596316 creator A5017885084 @default.
- W2614596316 creator A5018296872 @default.
- W2614596316 creator A5036682431 @default.
- W2614596316 creator A5037637971 @default.
- W2614596316 creator A5047538142 @default.
- W2614596316 creator A5049677416 @default.
- W2614596316 creator A5051870010 @default.
- W2614596316 creator A5053378499 @default.
- W2614596316 creator A5058275961 @default.
- W2614596316 creator A5068354355 @default.
- W2614596316 creator A5083687587 @default.
- W2614596316 date "2017-06-01" @default.
- W2614596316 modified "2023-10-10" @default.
- W2614596316 title "The FOXO3/PGC-1β signaling axis is essential for cancer stem cell properties of pancreatic ductal adenocarcinoma" @default.
- W2614596316 cites W1543159239 @default.
- W2614596316 cites W1624705676 @default.
- W2614596316 cites W1748668141 @default.
- W2614596316 cites W1931508686 @default.
- W2614596316 cites W1973566510 @default.
- W2614596316 cites W1985535740 @default.
- W2614596316 cites W1995103178 @default.
- W2614596316 cites W2001604240 @default.
- W2614596316 cites W2004177921 @default.
- W2614596316 cites W2004419844 @default.
- W2614596316 cites W2005404274 @default.
- W2614596316 cites W2019264784 @default.
- W2614596316 cites W2023300506 @default.
- W2614596316 cites W2026833147 @default.
- W2614596316 cites W2038988941 @default.
- W2614596316 cites W2043772793 @default.
- W2614596316 cites W2063703361 @default.
- W2614596316 cites W2074495107 @default.
- W2614596316 cites W2079148785 @default.
- W2614596316 cites W2097544430 @default.
- W2614596316 cites W2101616608 @default.
- W2614596316 cites W2111840545 @default.
- W2614596316 cites W2124195153 @default.
- W2614596316 cites W2135996922 @default.
- W2614596316 cites W2146138975 @default.
- W2614596316 cites W2151253787 @default.
- W2614596316 cites W2162399596 @default.
- W2614596316 cites W2167565365 @default.
- W2614596316 cites W2170552969 @default.
- W2614596316 cites W2170685293 @default.
- W2614596316 cites W2416315820 @default.
- W2614596316 cites W2558065385 @default.
- W2614596316 cites W4211208840 @default.
- W2614596316 cites W4243903519 @default.
- W2614596316 doi "https://doi.org/10.1074/jbc.m116.772111" @default.
- W2614596316 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5491768" @default.
- W2614596316 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28507102" @default.
- W2614596316 hasPublicationYear "2017" @default.
- W2614596316 type Work @default.
- W2614596316 sameAs 2614596316 @default.
- W2614596316 citedByCount "30" @default.
- W2614596316 countsByYear W26145963162017 @default.
- W2614596316 countsByYear W26145963162018 @default.
- W2614596316 countsByYear W26145963162019 @default.
- W2614596316 countsByYear W26145963162020 @default.
- W2614596316 countsByYear W26145963162021 @default.
- W2614596316 countsByYear W26145963162022 @default.
- W2614596316 countsByYear W26145963162023 @default.
- W2614596316 crossrefType "journal-article" @default.
- W2614596316 hasAuthorship W2614596316A5009883829 @default.
- W2614596316 hasAuthorship W2614596316A5010706963 @default.
- W2614596316 hasAuthorship W2614596316A5017885084 @default.
- W2614596316 hasAuthorship W2614596316A5018296872 @default.
- W2614596316 hasAuthorship W2614596316A5036682431 @default.
- W2614596316 hasAuthorship W2614596316A5037637971 @default.
- W2614596316 hasAuthorship W2614596316A5047538142 @default.
- W2614596316 hasAuthorship W2614596316A5049677416 @default.
- W2614596316 hasAuthorship W2614596316A5051870010 @default.
- W2614596316 hasAuthorship W2614596316A5053378499 @default.
- W2614596316 hasAuthorship W2614596316A5058275961 @default.
- W2614596316 hasAuthorship W2614596316A5068354355 @default.
- W2614596316 hasAuthorship W2614596316A5083687587 @default.
- W2614596316 hasBestOaLocation W26145963161 @default.
- W2614596316 hasConcept C121608353 @default.
- W2614596316 hasConcept C126322002 @default.
- W2614596316 hasConcept C168003608 @default.
- W2614596316 hasConcept C185592680 @default.
- W2614596316 hasConcept C190283241 @default.
- W2614596316 hasConcept C2780210213 @default.
- W2614596316 hasConcept C28328180 @default.
- W2614596316 hasConcept C2992026798 @default.
- W2614596316 hasConcept C502942594 @default.
- W2614596316 hasConcept C55427017 @default.
- W2614596316 hasConcept C55493867 @default.
- W2614596316 hasConcept C62478195 @default.
- W2614596316 hasConcept C71924100 @default.
- W2614596316 hasConcept C75217442 @default.
- W2614596316 hasConcept C86803240 @default.
- W2614596316 hasConcept C95444343 @default.
- W2614596316 hasConceptScore W2614596316C121608353 @default.